$796.68 Million in Sales Expected for Synopsys, Inc. (SNPS) This Quarter

Analysts expect Synopsys, Inc. (NASDAQ:SNPS) to post sales of $796.68 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Synopsys’ earnings. The lowest sales estimate is $791.30 million and the highest is $803.70 million. Synopsys reported sales of $769.43 million during the same quarter last year, which would suggest a positive year over year growth rate of 3.5%. The firm is scheduled to announce its next quarterly earnings results on Wednesday, February 20th.

On average, analysts expect that Synopsys will report full year sales of $3.32 billion for the current year, with estimates ranging from $3.30 billion to $3.33 billion. For the next financial year, analysts forecast that the firm will report sales of $3.53 billion, with estimates ranging from $3.48 billion to $3.60 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover Synopsys.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, December 5th. The semiconductor company reported $0.78 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.37. Synopsys had a net margin of 13.86% and a return on equity of 16.91%. The company had revenue of $795.08 million for the quarter, compared to analysts’ expectations of $794.55 million.

Several research firms recently commented on SNPS. Zacks Investment Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating and set a $105.00 price objective for the company in a report on Monday, December 10th. Needham & Company LLC lifted their target price on shares of Synopsys from $105.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, December 6th. Benchmark upgraded shares of Synopsys from a “hold” rating to a “buy” rating and set a $110.00 price objective on the stock in a research report on Thursday, December 6th. Berenberg Bank began coverage on shares of Synopsys in a research note on Tuesday, November 20th. They set a “buy” rating and a $119.00 target price on the stock. Finally, JPMorgan Chase & Co. raised shares of Synopsys from an “underweight” rating to a “neutral” rating and set a $98.00 target price on the stock in a research note on Tuesday, October 23rd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $109.25.

Shares of SNPS stock traded down $0.10 during trading hours on Wednesday, hitting $85.56. 68,060 shares of the company were exchanged, compared to its average volume of 1,358,122. The company has a quick ratio of 0.68, a current ratio of 0.73 and a debt-to-equity ratio of 0.04. Synopsys has a 52-week low of $80.13 and a 52-week high of $103.40. The firm has a market cap of $12.72 billion, a P/E ratio of 30.07, a PEG ratio of 3.21 and a beta of 1.29.

In related news, Chairman Geus Aart De sold 50,000 shares of Synopsys stock in a transaction that occurred on Monday, December 10th. The shares were sold at an average price of $89.34, for a total value of $4,467,000.00. Following the completion of the sale, the chairman now directly owns 23,757 shares in the company, valued at approximately $2,122,450.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Joseph W. Logan sold 20,000 shares of Synopsys stock in a transaction that occurred on Friday, December 7th. The stock was sold at an average price of $89.18, for a total transaction of $1,783,600.00. Following the completion of the sale, the executive vice president now owns 88,271 shares of the company’s stock, valued at $7,872,007.78. The disclosure for this sale can be found here. Insiders have sold a total of 73,611 shares of company stock worth $6,569,379 in the last three months. Insiders own 1.84% of the company’s stock.

Large investors have recently bought and sold shares of the company. Robecosam AG boosted its position in shares of Synopsys by 22.4% during the 2nd quarter. Robecosam AG now owns 3,000 shares of the semiconductor company’s stock valued at $255,000 after acquiring an additional 550 shares during the last quarter. Intrust Bank NA increased its stake in shares of Synopsys by 11.9% during the second quarter. Intrust Bank NA now owns 5,681 shares of the semiconductor company’s stock worth $486,000 after buying an additional 606 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Synopsys by 1.8% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 34,907 shares of the semiconductor company’s stock worth $3,442,000 after buying an additional 625 shares during the period. Gulf International Bank UK Ltd increased its stake in Synopsys by 1.4% in the third quarter. Gulf International Bank UK Ltd now owns 46,366 shares of the semiconductor company’s stock valued at $4,572,000 after purchasing an additional 647 shares during the last quarter. Finally, C M Bidwell & Associates Ltd. increased its stake in Synopsys by 7.3% in the third quarter. C M Bidwell & Associates Ltd. now owns 9,790 shares of the semiconductor company’s stock valued at $965,000 after purchasing an additional 670 shares during the last quarter. 89.17% of the stock is owned by hedge funds and other institutional investors.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation (EDA) software products used to design and test integrated circuits (ICs). It offers Galaxy Design platform that offers IC design solutions; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Story: What are retained earnings?

Get a free copy of the Zacks research report on Synopsys (SNPS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply